Alan Charles Bird

Affiliations: 
1969-2006 Institute of Ophthalmology, London, London, England, United Kingdom 
 1969-2006 Moorfields Eye Hospital 
Google:
"Alan Bird"
Bio:

Alan Charles Bird (born 4 July 1938, Bromley, Kent, UK) is an English ophthalmologist, famous for his work on degenerative and hereditary diseases of the retina.[1]

Bird was educated from 1949 to 1956 at Bromley Grammar School and from 1956 to 1961 at Guy's Hospital Medical School, where he studied neurology and neurosurgery and received his Bachelor of Medicine, Bachelor of Surgery (equivalent of MD in the United States). From July 1961 to January 1965 he held successive appointments at several hospitals in London. From January 1964 to December 1967 he served his ophthalmic residency at Moorfields Eye Hospital, then worked from December 1967 to June 1968 as senior registrar at the Royal London Hospital and the National Hospital for Nervous Diseases. From July 1968 to August 1969 he held a clinical fellowship in neuro-ophthalmology at Bascom Palmer Eye Institute, working with Lawton Smith, MD. Dr. Bird returned to Moorfield's in August 1969 and from 1969 to 1976 held successive appointed to the Institute of Ophthalmology as lecturer, senior lecturer and reader and then from 1976 to 2006 as professor, simultaneously serving as consultant at Moorfields Eye Hospital.[2]

In order to contribute fully to research, Dr. Bird spent a sabbatical period with Dean Bok, MD, at UCLA in 1985. In addition to his work in London, he has also spent time in Africa undertaking research into river blindness. Most notable was the finding that retinal and optic nerve disease was the main cause of blindness, rather than corneal scarring, and that the standard treatment of diethyl carbamizine citrate caused rapid onset of blindness. This led to the institution of ivermectin as the preferred treatment, which has been highly successful. He has also worked in Jamaica recording the retinal changes in sickle cell disease over a 20-year period in a well-studied cohort generated by Graham Serjeant, MD.[3]

Dr. Bird is the author or co-author of more than 400 publications in peer-reviewed journals. He has given numerous named lectures in Europe and North America.

He is married and the father of two children.
(Show less)

Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Chandra S, Grewal MK, Gurudas S, et al. (2023) Quantitative Autofluorescence in Non-Neovascular Age Related Macular Degeneration. Biomedicines. 11
Chew EY, Peto T, Clemons TE, et al. (2022) Macular Telangiectasia Type 2: A Classification System Using MultiModal Imaging MacTel Project Report Number 10. Ophthalmology Science. 3: 100261
Grewal MK, Chandra S, Bird A, et al. (2021) Scotopic thresholds on dark-adapted chromatic perimetry in healthy aging and age-related macular degeneration. Scientific Reports. 11: 10349
Mueller S, Gunnemann F, Rothaus K, et al. (2021) Incidence and phenotypical variation of outer retina-associated hyperreflectivity in macular telangiectasia type 2. The British Journal of Ophthalmology
Bird A. (2020) Role of retinal pigment epithelium in age-related macular disease: a systematic review. The British Journal of Ophthalmology
Grewal MK, Chandra S, Gurudas S, et al. (2020) Exploratory Study on Visual Acuity and Patient-Perceived Visual Function in Patients with Subretinal Drusenoid Deposits. Journal of Clinical Medicine. 9: 2832
Grewal MK, Sivapathasuntharam C, Chandra S, et al. (2020) A Pilot Study Evaluating the Effects of 670 nm Photobiomodulation in Healthy Ageing and Age-Related Macular Degeneration. Journal of Clinical Medicine. 9
Mahroo OA, Arno G, Ba-Abbad R, et al. (2019) Reanalysis of Association of Pro50Leu Substitution in Guanylate Cyclase Activating Protein-1 With Dominant Retinal Dystrophy. Jama Ophthalmology
Guymer RH, Rosenfeld PJ, Curcio CA, et al. (2019) Incomplete Retinal Pigment Epithelial and Outer Retinal Atrophy in Age-Related Macular Degeneration: Classification of Atrophy Meeting Report 4. Ophthalmology
Pauleikhoff D, Bonelli R, Dubis AM, et al. (2019) Progression characteristics of ellipsoid zone loss in macular telangiectasia type 2. Acta Ophthalmologica
See more...